Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0362 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0309 | 0.8184 | 0.7953 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.02 | 0.4478 | 0.0231 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.02 | 0.4478 | 0.0231 |
Echinococcus multilocularis | geminin | 0.0362 | 1 | 1 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0167 | 0.336 | 0.2514 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0167 | 0.3344 | 0.2496 |
Toxoplasma gondii | 5'-nucleotidase, C-terminal domain-containing protein | 0.0167 | 0.336 | 1 |
Treponema pallidum | 5'-nucleotidase (ushA) | 0.0167 | 0.336 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4348 | 0.3628 |
Schistosoma mansoni | hypothetical protein | 0.0362 | 1 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4348 | 0.3628 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibition of human Ecto-5'-NT expressed in african green monkey COS7 cells using AMP as substrate at 0.1 mM preincubated for 10 mins measured after 10 mins | ChEMBL. | 23831808 |
Inhibition (binding) | = 30.08 % | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells at 1 mM preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 33.5 uM | Inhibition of bovine intestinal alkaline phosphatase using p-NPP as substrate treated 10 mins before substrate addition measured after 30 mins by spectrophotometric assay | ChEMBL. | 23831808 |
Ki (binding) | = 41 uM | Inhibition of bovine kidney intestinal alkaline phosphatase using p-NPP as substrate treated 10 mins before substrate addition measured after 30 mins by spectrophotometric assay | ChEMBL. | 23831808 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.